KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) Net Income towards Common Stockholders (2018 - 2025)

Historic Net Income towards Common Stockholders for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $91.3 million.

  • BioNTech SE's Net Income towards Common Stockholders fell 5803.26% to $91.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$605.1 million, marking a year-over-year decrease of 98240.58%. This contributed to the annual value of -$737.4 million for FY2024, which is 14753.38% down from last year.
  • Per BioNTech SE's latest filing, its Net Income towards Common Stockholders stood at $91.3 million for Q3 2025, which was down 5803.26% from -$474.1 million recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Net Income towards Common Stockholders registered a high of $7.1 billion during Q1 2022, and its lowest value of -$865.6 million during Q2 2024.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was $277.3 million (2024), whereas its average is $1.3 billion.
  • Per our database at Business Quant, BioNTech SE's Net Income towards Common Stockholders surged by 6418573663.12% in 2022 and then crashed by 31749.74% in 2024.
  • BioNTech SE's Net Income towards Common Stockholders (Quarter) stood at $3622.0 in 2021, then skyrocketed by 64185736.63% to $2.3 billion in 2022, then tumbled by 59.81% to $934.5 million in 2023, then crashed by 70.32% to $277.3 million in 2024, then plummeted by 67.07% to $91.3 million in 2025.
  • Its Net Income towards Common Stockholders was $91.3 million in Q3 2025, compared to -$474.1 million in Q2 2025 and -$499.6 million in Q1 2025.